Hong T, Chang A, Maddess T, Provis J, Penfold P. Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy. BMJ Open Ophthalmology 2022;0:e001032. doi:10.1136/bmjophth-2022-001032

Hong T, Chang A, Maddess T, Provis J, Penfold P. Phase 1B study of the safety and tolerability of the mineralocorticoid fludrocortisone acetate in patients with geographical atrophy. BMJ Open Ophthalmology 2022;0:e001032. doi:10.1136/bmjophth-2022-001032

Related Publications

Our Affiliates